BP
Balaji Prasad Barclays Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Evolus
EOLS
$492M
| $7.39 | $25 |
238%
upside
| Overweight |
5 Mar ‘25
6 months ago |
|
2
Amneal Pharmaceuticals
AMRX
$3.11B
| $9.89 | $11 |
11%
upside
| Overweight |
3 Mar ‘25
6 months ago |
|
3
Pacira BioSciences
PCRX
$1.2B
| $26.30 | $24 |
9%
downside
| Overweight |
28 Feb ‘25
6 months ago |
|
4
Viatris
VTRS
$12.2B
| $10.45 | $9 |
14%
downside
| Underweight |
28 Feb ‘25
6 months ago |
|
5
Jazz Pharmaceuticals
JAZZ
$7.88B
| $128.53 | $200 |
56%
upside
| Overweight |
27 Feb ‘25
6 months ago |
|
6
Elanco Animal Health
ELAN
$9.32B
| $18.76 | $19 |
1%
upside
| Overweight |
26 Feb ‘25
6 months ago |
|
7
Tarsus Pharmaceuticals
TARS
$2.4B
| $56.49 | $60 |
6%
upside
| Overweight |
26 Feb ‘25
6 months ago |
|
8
Zoetis
ZTS
$67.3B
| $149.79 | $244 |
63%
upside
| Overweight |
14 Feb ‘25
6 months ago |
|
9
Organon & Co
OGN
$2.7B
| $10.37 | $24 |
131%
upside
| Overweight |
14 Feb ‘25
6 months ago |
|
10
Phibro Animal Health
PAHC
$1.6B
| $41.23 | $22 |
47%
downside
| Underweight |
10 Feb ‘25
7 months ago |
|
11
Idexx Laboratories
IDXX
$52.2B
| $655.60 | $520 |
21%
downside
| Overweight |
4 Feb ‘25
7 months ago |
|
12
Teva Pharmaceuticals
TEVA
$22.6B
| $19.68 | $26 |
32%
upside
| Overweight |
30 Jan ‘25
7 months ago |
|
13
Ligand Pharmaceuticals
LGND
$3.22B
| $165.41 | $160 |
3%
downside
| Overweight |
16 Dec ‘24
8 months ago |
|
14
Dr. Reddy's Laboratories
RDY
$12.1B
| $14.58 | $17 |
17%
upside
| Overweight |
6 Nov ‘24
10 months ago |
|
15
Alvotech
ALVO
$2.54B
| $8.11 | $18 |
122%
upside
| Overweight |
25 Jul ‘24
1 year ago |
|
16
PolyPid
PYPD
$55M
| $3.49 | $10 |
187%
upside
| Equal-Weight |
23 Oct ‘23
1 year ago |
|
17
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| $1.35 | $7 |
419%
upside
| Overweight |
23 Oct ‘23
1 year ago |
|
18
VYNE Therapeutics
VYNE
$7.31M
| $0.2870 | $8 |
2,687%
upside
| Overweight |
25 Mar ‘20
5 years ago |
|